What's new in Hodgkin's lymphoma: ASH 2012 and more

被引：0
|
作者：
Melchardt T. [1 ]
Weiss L. [1 ]
Greil R. [1 ]
Egle A. [1 ]
机构：
[1] Department of Internal Medicine III with Hematology, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48
来源：
memo - Magazine of European Medical Oncology | 2013年 / 6卷 / 3期
关键词：
BEACOPPesc; Brentuximab vedotin; Hodgkin's lymphoma; PET-CT;
D O I：
10.1007/s12254-013-0095-7
中图分类号：
学科分类号：
摘要：
Modern treatment strategies have resulted in an excellent overall survival in the majority of patients with Hodgkin's lymphoma. PET-stratification is used to guide treatment in patients with limited disease in clinical trials, but recent results indicate that combined treatment with chemotherapy and radiotherapy is still the standard of care. Prediction of treatment related mortality and new data about chemotherapy induced infertility will guide our decisions especially in patients with advanced disease and brentuximab vedotin is now an approved option in patients with relapsed or refractory disease. © Springer-Verlag Wien 2013.
引用
收藏
页码：193 / 196
页数：3
相关论文
共 50 条
  • [21] Synchronous Hodgkin’s lymphoma and schwannomas mimicking refractory Hodgkin’s lymphoma
    Onno C. Leeksma
    Rick L. M. Haas
    Frederik N. Hofman
    Theo J. Hulsebos
    Theo A. M. van Os
    Aart Brutel de la Rivière
    Annals of Hematology, 2015, 94 : 1593 - 1595
  • [22] Hypertension 2012 - What's New?
    Wenzel, R. R.
    Wenzel, M. Q.
    JOURNAL FUR HYPERTONIE, 2013, 17 (01): : 11 - 13
  • [23] New drugs and targeted treatments in Hodgkin's lymphoma
    Provencio, Mariano
    Sanchez, Antonio
    Sanchez-Beato, Margarita
    CANCER TREATMENT REVIEWS, 2014, 40 (03) : 457 - 464
  • [24] Relapsed and refractory Hodgkin's lymphoma: New avenues?
    Canellos, George P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) : 929 - +
  • [25] A new approach to non-Hodgkin's lymphoma
    Hauke, RJ
    Armitage, JO
    INTERNAL MEDICINE, 2000, 39 (03) : 197 - 208
  • [26] New frontiers in allogeneic transplantation for Hodgkin's lymphoma
    Anderlini, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 19 - 20
  • [27] New drugs in non-Hodgkin's lymphoma
    Arbuck, SG
    Sorensen, JM
    Christian, MC
    Ho, P
    Pluda, JM
    Cheson, BD
    ANNALS OF ONCOLOGY, 1997, 8 : 119 - 128
  • [28] New developments in the treatment of advanced Hodgkin's lymphoma
    Kreissl, S.
    Eichenauer, D.
    Borchmann, P.
    ONKOLOGE, 2014, 20 (05): : 457 - +
  • [29] A new option for relapsed or refractory Hodgkin's lymphoma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2012, 13 (05): : E192 - E192
  • [30] New treatment for relapsed or refractory Hodgkin's lymphoma
    Gourd, Elizabeth
    LANCET ONCOLOGY, 2019, 20 (06): : E298 - E298
12345